Latest news with #StephanieDiaz
Yahoo
27-03-2025
- Business
- Yahoo
Lifecore Biomedical to Report Financial Results for Third Quarter of Fiscal 2025 on April 3, 2025
Webcast Scheduled for Thursday, April 3 at 4:30 p.m. Eastern CHASKA, Minn., March 27, 2025 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. (NASDAQ: LFCR) ('Lifecore'), a fully integrated contract development and manufacturing organization ('CDMO'), today announced that it will report financial results for the third quarter of fiscal year 2025 on Thursday, April 3, 2025, after market close. At 4:30 p.m. Eastern Time that day, members of Lifecore's senior management team will host a webcast to discuss financial results for the quarter and review recent corporate developments. To listen to the live webcast, or access the archived webcast, please visit the Investor Events & Presentations page of Lifecore's website at: Following the live webcast, an archived version of the webcast will be available on the company's website for 30 days. About Lifecore Biomedical Lifecore Biomedical, Inc. (Nasdaq: LFCR) is a fully integrated contract development and manufacturing organization (CDMO) that offers highly differentiated capabilities in the development, fill and finish of sterile injectable pharmaceutical products in syringes, vials, and cartridges, including complex formulations. As a leading manufacturer of premium, injectable-grade hyaluronic acid, Lifecore brings more than 40 years of expertise as a partner for global and emerging biopharmaceutical and biotechnology companies across multiple therapeutic categories to bring their innovations to market. For more information about the company, visit Lifecore's website at CONTACT: Lifecore Biomedical, Inc. Contact Information: Vida Strategic Partners Stephanie Diaz (Investors) 415-675-7401 sdiaz@ Tim Brons (Media) 415-675-7402 tbrons@ Ryan D. Lake (CFO) Lifecore Biomedical 952-368-6244
Yahoo
10-02-2025
- Business
- Yahoo
Avid Bioservices Launches New Company Website Designed to Boost Company Brand Awareness and Enhance the Visitor Experience
TUSTIN, Calif., Feb. 10, 2025 (GLOBE NEWSWIRE) -- Avid Bioservices, Inc. (NASDAQ: CDMO), a dedicated biologics contract development and manufacturing organization (CDMO) working to improve patient lives by providing high quality development and manufacturing services to biotechnology and pharmaceutical companies, today announced the launch of its new corporate website. The new site, which can be visited at combines Avid's elevated brand story and visual identity with improved functionality and navigation, all aimed at enhancing the visitor experience, particularly for current and prospective customers. The reimagined Avid website captures the company's elevated brand through the tagline, 'Discover the Avid effect.™', helping educate visitors on the differentiation that positions the company as one of the industry's leading, most trusted biologics CDMOs. It offers a completely revamped customer experience highlighted by user-friendly navigation, improved accessibility, video interaction, and educational resources. 'As a company that places the highest priority on delivering exceptional quality service and exceeding the expectations of our customers, we felt compelled to bring that same ethos to our online presence,' said Nick Green, president and chief executive officer of Avid. 'We take great pride in unveiling our new company website as a showcase to the Avid brand, capturing the spirit of our team, our unrivaled expertise, world-class facilities, and personalized process. For those that already have a relationship with Avid, we expect the new site will align with their experience. For those just getting to know us, we hope it will serve as a trusted and valuable resource for exploration, education, and engagement.' About Avid Bioservices, Inc. Avid Bioservices (NASDAQ: CDMO) is a dedicated contract development and manufacturing organization (CDMO) focused on development and CGMP manufacturing of biologics. The company provides a comprehensive range of process development, CGMP clinical and commercial manufacturing services for the biotechnology and biopharmaceutical industries. With more than 30 years of experience producing biologics, Avid's services include CGMP clinical and commercial drug substance manufacturing, bulk packaging, release and stability testing and regulatory submissions support. For early-stage programs the company provides a variety of process development activities, including cell line development, upstream and downstream development and optimization, analytical methods development, testing and characterization. The scope of our services ranges from standalone process development projects to full development and manufacturing programs through commercialization. CONTACT: Contacts: Stephanie Diaz (Investors) Vida Strategic Partners 415-675-7401 sdiaz@ Tim Brons (Media) Vida Strategic Partners 415-675-7402 tbrons@ in to access your portfolio
Yahoo
27-01-2025
- Health
- Yahoo
‘That's a big number;' Almost 4 million new positive cases of bird flu in Miami Valley
There are big concerns over higher bird flu cases across the region. [DOWNLOAD: Free WHIO-TV News app for alerts as news breaks] We are looking at the worries people have and what this could mean for costs at the grocery store this morning on News Center 7 Daybreak. TRENDING STORIES: Firefighter arrested on prostitution, drug charges Deputies, medics respond to reported shooting in Clark County Car break-in victim takes back gun, holds down suspect until officers arrive, police say Nearly four million commercial chickens and more than 86,000 commercial turkeys in Darke and Mercer counties were confirmed positive for bird flu by the National Veterinary Services Laboratory in 10 reports on Jan. 23 and Jan. 24, according to the Ohio Department of Agriculture (ODA). More than 1.9 million birds have been 'depopulated.' ODA's procedure is to quarantine the impacted facility and to depopulate, or kill, the birds to prevent the disease from spreading. ODA's report indicates that the process of depopulating the remaining 1.8 million birds is ongoing. Another 190,000 commercial chickens have been depopulated in Darke County but is unclear if they tested positive for bird flu, according to ODA's report. A grocery store customer told News Center 7 that she was not happy at possibly paying higher grocery store prices. 'That's a big number, because the poultry farmers, they got to destroy all of the chickens and turkeys and left them to drive up the price of food in the grocery store,' said Stephanie Diaz. The exact location of where these birds were in the Miami Valley was not initially released. News Center 7 will continue to follow this story. [SIGN UP: WHIO-TV Daily Headlines Newsletter]
